Restylane Lyft Lidocaine
Sponsors
Galderma R&D, Merz North America, Inc.
Conditions
Cheek AugmentationCheek Volume AugmentationCheek WrinklesChin AugmentationJawline DefinitionMidface Contour DeficienciesSafetyVolume Deficiency of the Midface
Unknown Phase
A Study to Evaluate the Safety Following Injection of GP0045 Compared to Restylane Lyft Lidocaine
CompletedNCT03133325
Start: 2017-04-19End: 2017-07-13Updated: 2022-08-25
A Study to Evaluate Effectiveness and Safety of Hyaluronic Acid (HA) Fillers
CompletedNCT03869450
Start: 2018-11-09End: 2019-08-30Updated: 2022-08-26
Study to Evaluate Satisfaction After Treatment With Restylane
CompletedNCT04638816
Start: 2021-04-16End: 2021-08-20Updated: 2024-03-06
A Prospective, Multicenter, Randomized, Comparator-controlled, Evaluator-blinded Study to Evaluate the Safety and Effectiveness of VP1 Lido US for Volume Augmentation of the Cheek
CompletedNCT04886232
Start: 2021-05-25End: 2023-05-16Updated: 2023-05-24
Safety and Effectiveness of GP0112 for Cheek Augmentation and Correction
WithdrawnNCT05098457
Start: 2022-02-22End: 2023-11-18Updated: 2022-08-25
Safety and Effectiveness of GP0112 for Cheek Augmentation and Correction of Midface Contour Deficiencies
CompletedNCT05262777
Start: 2022-05-02End: 2024-03-05Updated: 2024-04-09
Effectiveness and Safety of Restylane Lyft Lidocaine for Jawline Definition
CompletedNCT05622812
Start: 2023-02-16End: 2024-06-14Updated: 2025-03-07
A Restylane Treatment Algorithm Approach for Participants With Appearance of Insufficient Bone Structure in the Lower Face Alone or in Combination With Facial Soft Tissue Deficiencies
CompletedNCT06428214
Start: 2024-05-13End: 2024-09-24Updated: 2025-01-31